Science
Mechanism of Action
TRIETHOXYSILYLPROPYL ACETYL HYDROXYPROLINATE works by introducing N-acetyl-L-hydroxyproline (NAHP), which has demonstrated efficacy in inhibiting the formation of Advanced Glycation End-products (AGEs) both in vitro and ex vivo. Furthermore, it helps prevent the degradation of cellular contractile forces within a glycated dermis model, thereby actively mitigating AGE-induced alterations in human skin, such as dermal stiffening and the development of a yellowish complexion.
Research
Clinical Evidence
Insufficient-data confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Safety
Safety Profile
Independent safety assessments by recognized regulatory bodies such as CIR, SCCS, or FDA are currently unavailable for this specific ingredient.
Your Skin
Skin Compatibility
Our Assessment
Verdict
While exhibiting a promising anti-glycation mechanism in initial studies, the absence of comprehensive clinical efficacy and safety data renders its overall utility for precision skincare currently undeterminable.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources